The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial
Top Cited Papers
Open Access
- 25 July 2002
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 118 (2), 385-400
- https://doi.org/10.1046/j.1365-2141.2002.03724.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 26 references indexed in Scilit:
- A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer GroupBlood, 2001
- Randomised studies in acute myeloid leukaemia: the double truthBone Marrow Transplantation, 2000
- A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trialBritish Journal of Haematology, 1999
- What is in store after stem-cell transplantation?The Lancet, 1999
- Transplantation in First Remission of Acute Myeloid LeukemiaNew England Journal of Medicine, 1998
- All-trans-Retinoic Acid in Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1997
- Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trialBone Marrow Transplantation, 1997
- Autologous Bone Marrow Transplantation versus Intensive Consolidation Chemotherapy for Acute Myeloid Leukemia in ChildhoodNew England Journal of Medicine, 1996
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994